MediPharm Labs Corp.

LABS.TOTSXHealthcare● Active

$0.07

+$0.00(+0.00%)

Market Cap$29740480

P/E Ratio—

52W High$0.1

52W Low$0.06

Avg Volume302K

Open$0.08

Beta0.89

Net Income Financials Revenue

MediPharm Labs Corp. (LABS.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LABS.TO · net income · updated Jun 8, 2026

Core profitability metrics

LABS.TO · net income · margin · TTM · CAGR

Net income was −$8.3M for FY2025 (fiscal year ending 2025-12-31), up 22.7% year-over-year. Net profit margin was -18.3%. Based on available data, MediPharm Labs Corp. has been profitable since at least 2019.

FY2025 Net Income−$8.3M▲ +22.7% YoY

Trailing 12M (TTM)−$8.7Mtrailing 4 quarters sum

Net Profit Margin-18.3%−$8.3M ÷ $45.1M

YoY Change+22.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · LABS.TO net income history · LABS.TO profit margin

Annual net income data

LABS.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$8.3M▲ +22.7%-18.3%$45.1M

FY2024Loss−$10.7M▲ +18.3%-25.5%$42.0M

FY2023Loss−$13.1M▲ +56.4%-39.6%$33.1M

FY2022Loss−$30.0M▲ +45.3%-135.6%$22.1M

FY2021Loss−$54.8M▲ +18.3%-252.4%$21.7M

Net income vs peers (Healthcare)

LABS.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

MediPharm Labs Corp.YOU

LABS.TO

−$8.3M+22.7%-18.3%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

MediPharm Labs Corp. (LABS.TO) reported net income of −$8.3M for FY2025 (fiscal year ending 2025-12-31), up 22.7% year-over-year. The net profit margin was -18.3% — meaning the company kept $-0.18 of every dollar of revenue as profit.

Based on available data, MediPharm Labs Corp. has been profitable since at least 2019. Net income reached a peak of $1.1M in FY2019. Data available for 10 fiscal years.

MediPharm Labs Corp.'s net profit margin was -18.3% for FY2025, based on the latest annual results.

Investors sometimes search for "MediPharm Labs Corp. net worth" — the company's market capitalization is a separate figure from LABS.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

LABS.TO net income · 4 questions

MediPharm Labs Corp. is not currently profitable on an annual basis. The company reported a net loss of $8.3M for FY2025.

is LABS.TO profitabledoes LABS.TO make a profitLABS.TO profitabilityLABS.TO profitable company

▸ Source: FMP /income-statement · GAAP · MediPharm Labs Corp. · MediPharm Labs Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026